Abstract
Antipsychotic medicines are the cornerstone pharmacotherapy for patients with psychotic disorders. Early and continuous management of psychoses improves the quality of life, decreases hospitalization and reduces medical costs. However, many psychotic patients are not fully compliant with treatment, and thus they more often experience a relapsing course with a suboptimal clinical outcome. Long-term parenteral antipsychotic agents may improve compliance by offering clear evidence of medication non-compliance and documented drug administration monitoring. Using injection therapy might be especially beneficial to poorly compliant individuals with their first-psychotic episode and those with severe psychopathology or comorbid substance abuse. The availability of five different antipsychotic drug depot medications offers diverse treatment options which can be individualized for each case.
Keywords: Injectable antipsychotic medications, depot neuroleptic agents, haloperidol decanoate, fluphenazine decanoate, long-acting risperidone, paliperidone palmitate, long-acting olanzapine, psychotherapy, CATIE, neuroleptic
Current Drug Targets
Title: Long-Acting Antipsychotic Medications
Volume: 13 Issue: 4
Author(s): Raman Baweja, Karim Sedky and Steven Lippmann
Affiliation:
Keywords: Injectable antipsychotic medications, depot neuroleptic agents, haloperidol decanoate, fluphenazine decanoate, long-acting risperidone, paliperidone palmitate, long-acting olanzapine, psychotherapy, CATIE, neuroleptic
Abstract: Antipsychotic medicines are the cornerstone pharmacotherapy for patients with psychotic disorders. Early and continuous management of psychoses improves the quality of life, decreases hospitalization and reduces medical costs. However, many psychotic patients are not fully compliant with treatment, and thus they more often experience a relapsing course with a suboptimal clinical outcome. Long-term parenteral antipsychotic agents may improve compliance by offering clear evidence of medication non-compliance and documented drug administration monitoring. Using injection therapy might be especially beneficial to poorly compliant individuals with their first-psychotic episode and those with severe psychopathology or comorbid substance abuse. The availability of five different antipsychotic drug depot medications offers diverse treatment options which can be individualized for each case.
Export Options
About this article
Cite this article as:
Baweja Raman, Sedky Karim and Lippmann Steven, Long-Acting Antipsychotic Medications, Current Drug Targets 2012; 13 (4) . https://dx.doi.org/10.2174/138945012799499785
DOI https://dx.doi.org/10.2174/138945012799499785 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genes Involved in Hereditary Hearing Impairment
Current Genomics Editorial [Hot Topic Biomarkers, Molecular Imaging, and Novel Therapies of Cancer]
Current Molecular Medicine Mass Spectrometry-Based Metabolic Profiling
Current Metabolomics Targeting Apelinergic System in Cardiometabolic Disease
Current Drug Targets Recent Advances in Antiarrhythmic Drug Treatment of Atrial Fibrillation
Recent Patents on Cardiovascular Drug Discovery Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature
Current Diabetes Reviews In-Vivo Gene Delivery by Sonoporation: Recent Progress and Prospects
Current Gene Therapy Flavonoids, Vascular Function and Cardiovascular Protection
Current Pharmaceutical Design Current Outcomes and Considerations in Hypoplastic Left Heart Syndrome
Current Pediatric Reviews Lipid Raft in Cardiac Health and Disease
Current Cardiology Reviews Helicobacter pylori Eradication Improves the Malnutrition, Inflammation and Atherosclerosis Syndrome in Peritoneal Dialysis Patients
Vascular Disease Prevention (Discontinued) The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary
Current Cardiology Reviews Adhatoda vasica Nees: Phytochemical and Pharmacological Profile
The Natural Products Journal High-Density Lipoprotein: Key Molecule in Cholesterol Efflux and the Prevention of Atherosclerosis
Current Pharmaceutical Design Synergistic Antitumor Effect of 5-Fluorouracil Combined with Constituents from <i>Pleurospermum lindleyanum</i> in Hepatocellular Carcinoma SMMC-7721 Cells
Anti-Cancer Agents in Medicinal Chemistry Hypertension and Cardiac Arrhythmias
Current Pharmaceutical Design Treatment of Periodontitis for the Prevention of Endothelial Dysfunction: A Narrative Review
Current Vascular Pharmacology IL-6 Signaling and its Blockade with a Humanized Anti-Interleukin-6 Receptor Antibody in Rheumatoid Arthritis: Advent of a New and Innovative Therapeutic Drug, Tocilizumab
Current Rheumatology Reviews Effects of Low Doses of Polyunsaturated Fatty Acids on the Attention Deficit/Hyperactivity Disorder of Children: A Systematic Review
Current Neuropharmacology Endothelial Function Assessment in Complicated Hypertension
Current Pharmaceutical Design